Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsShortsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Kate A. Yeager, PhD, RN, FAAN

Advertisement

Articles by Kate A. Yeager, PhD, RN, FAAN

Capturing the Patient's Voice: Reporting Cancer Treatment Toxicities in Clinical Trials

ByJanice Withycombe, PhD, MN, CCRP,Kate A. Yeager, PhD, RN, FAAN
April 18th 2017

The voice of the patient during clinical trials must be captured, to fully record the impact of treatment toxicity and symptoms.

Advertisement

Latest Updated Articles

  • Capturing the Patient's Voice: Reporting Cancer Treatment Toxicities in Clinical Trials
    Capturing the Patient's Voice: Reporting Cancer Treatment Toxicities in Clinical Trials

    April 18th 2017



Advertisement
Advertisement

Trending on Oncology Nursing News

1

AI and ctDNA: Advancing Precision Bladder Cancer Care

2

FDA Approves Belzutifan/Pembrolizumab for Adjuvant Renal Cell Carcinoma

3

FDA Approves Capivasertib for PTEN-Deficient Prostate Cancer

4

Rethinking Proton Pump Inhibitors in Glioblastoma Care

5

How Nurses Can Save Lives Beyond the Bedside

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us